Cancer On-Demand Webinars

Oct | 2017

• Presenters: Len Neckers, PhD, Senior Investigator, National Cancer Institute, Center for Cancer Research; Josip Blonder, MD, Senior Scientist, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research (FNLCR); et al.
• Abstract

  Cancer research has made major advancements in diagnosis, treatments, and the basic understanding of the disease itself. Within the last year, we have seen progress in immunotherapy, treatments involving nanotechnology, advances in targeted and personalized therapeutics and drug development, and a decrease in mortality rates due to a strong focus on learning more about the origination of the disease.
  
  Cancer Research & Oncology 2017 will focus on advancements in prevention, diagnosis and treatment of different cancer types. The world’s thought leaders in cancer research will present their latest discoveries in cancer mechanics and detection as well as clinical aspects such as targeted therapies and novel treatments, all in an international venue conducive to networking.
  
  Topics for this year's virtual conference include:

  • Computational Oncology
  • Data and Bioinformatics
  • Organ Systems & Oncogenes
  • Breast
  • Urologic Oncology
  • KRas-driven cancers
  • Circulating Tumor Cells
  • Therapeutics and Anti-cancer Drug Discovery
  • Traditional vs novel therapeutics
  • Cancer Diagnostics, Screening and Imaging
  • Personalized diagnostics
  • Industry Landscape

Oct | 2013

• Presenters: Dr. Brian Haab, Associate Professor, Van Andel Research Institute Center for Translational Medicine and Dr. Beatriz M. Carreno , Research Associate Professor, Washington University School of Medicine
• Abstract

  Multiplex assays allow simultaneous detection of multiple analytes (up to hundreds) in a single run, and can be used for studying proteins or nucleic acids. In this webinar, Dr. Brian Haab (Van Andel Research Institute) will discuss some of the major technologies used to discover and validate protein biomarkers in a multiplex format (e.g., antibody arrays and bead-based technologies), describing important considerations for each, including the relative requirements for specificity, sensitivity, throughput, and multiplexing; the process of ensuring valid and reproducible results; and the practicality and flexibility of the platforms. Dr. Beatriz Carreno (Washington University School of Medicine in St. Louis) will then discuss the use of MILLIPLEX^® MAP assays, based on the Luminex^® xMAP^® technology, to study the characteristics of a novel melanoma-specific dendritic cell vaccine and the identification of potential biomarkers of clinical efficacy. Dr. Debra MacIvor (Product Manager with Merck) will briefly describe the breadth of the MILLIPLEX^® MAP cancer research portfolio.

May | 2013

• Presenters: Andrew Ball, Ph.D., R&D Manager, Merck and KC Huang, Ph.D., Assistant Professor of Bioengineering, Stanford University
• Abstract

  Cell cultures, by definition, inhabit the unsteady ground between tight, reproducible experimental control and the ability to simulate the complex and dynamic environments found in vivo. This webcast reveals how pioneering microfluidic technology enables the precise manipulation of physiologically relevant micro-environments, helping researchers connect cellular mechanisms with phenotypes and disease states.
  
  Microfluidic cell culture chambers allow crucial parameters such as media flow, temperature and gas environment to be automated. This enables researchers to recreate the mass transport environment of tissues, elicit cell responses to dynamic solution changes and enable long-term perfusion culture – a real-time, live cell analysis with unprecedented control. 
  
  The first speaker, Dr. Andrew Ball, will review a specific workflow involving microfluidic chambers used with a fluorescent microscope and image analysis software, to provide insights for live cell dynamic applications such as host-pathogen interactions, cancer cell autophagy, and cell migration in a standardized format. 
  
  Then, Dr. KC Huang, will discuss how specific microfluidic techniques have allowed him to study damped oscillations of bacterial growth in response to osmotic shock. Dr. Huang will describe the advantages of real-time, live cell analysis in a microfluidic context. 
  
  In this webinar you learn:

  • The advantages and challenges of using microfludic cell culture tools in cell biology
  • Techniques that can be used to develop and quantify in vitro cell models for predictive cell analysis.